Total Debt for Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported total debt is $67.42B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
PFE
Currently viewingTotal DebtSwitch metric
Latest period
$67.42B
YoY change
+0.6%
5Y CAGR
+12.0%
Peak year (2023)
$70.84B
Latest annual
$67.42B
Total Debt history chart for Pfizer (PFE) from 1985 to 2025
Total Debt history table for Pfizer (PFE) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $67.42B | +0.6% | ||
| 2024 | $66.99B | -5.4% | ||
| 2023 | $70.84B | +103.2% | ||
| 2022 | $34.86B | -5.8% | ||
| 2021 | $37.00B | -3.3% | ||
| 2020 | $38.27B | -24.7% | ||
| 2019 | $50.84B | +21.8% | ||
| 2018 | $41.74B | -2.0% | ||
| 2017 | $42.61B | +3.8% | ||
| 2016 | $41.06B | +5.6% | ||
| 2015 | $38.90B | +6.0% | ||
| 2014 | $36.68B | +0.5% | ||
| 2013 | $36.49B | -2.6% | ||
| 2012 | $37.46B | -3.8% | ||
| 2011 | $38.94B | -11.6% | ||
| 2010 | $44.03B | -9.5% | ||
| 2009 | $48.66B | +181.6% | ||
| 2008 | $17.28B | +31.5% | ||
| 2007 | $13.14B | +64.6% | ||
| 2006 | $7.98B | -55.5% | ||
| 2005 | $17.94B | -3.3% | ||
| 2004 | $18.55B | +27.3% | ||
| 2003 | $14.57B | +23.4% | ||
| 2002 | $11.81B | +33.1% | ||
| 2001 | $8.87B | +63.9% | ||
| 2000 | $5.41B | -23.5% | ||
| 1999 | $7.07B | +117.2% | ||
| 1998 | $3.26B | +9.4% | ||
| 1997 | $2.98B | +1.8% | ||
| 1996 | $2.92B | +1.9% | ||
| 1995 | $2.87B | +1.6% | ||
| 1994 | $2.82B | +61.4% | ||
| 1993 | $1.75B | -4.1% | ||
| 1992 | $1.82B | -12.7% | ||
| 1991 | $2.09B | +23.3% | ||
| 1990 | $1.69B | -1.4% | ||
| 1989 | $1.72B | +43.7% | ||
| 1988 | $1.19B | +23.9% | ||
| 1987 | $963.80M | +73.1% | ||
| 1986 | $556.70M | +9.3% | ||
| 1985 | $509.40M | — |
Total Debt values are taken from Pfizer's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Pfizer (PFE) total debt totalled $67.42B – edged up 0.6% year-over-year.
Pfizer total debt compound annual growth for the 2020–2025 (5 years) window is +12.0%, with the latest reading among the more recent periods of the dataset.
2023 marks the peak total debt at $70.84B, with the historical low of $509.40M recorded in 1985.
Among 8 Healthcare peers, Pfizer (PFE) ranks 4th; the peer median for total debt is $52.57B.
Pfizer Total Debt by Year
Pfizer Total Debt 2025: $67.42B
Pfizer total debt in 2025 was $67.42B, edged up 0.6% from 2024.
Pfizer Total Debt 2024: $66.99B
Pfizer total debt in 2024 was $66.99B, declined 5.4% below 2023.
Pfizer Total Debt 2023: $70.84B
Pfizer total debt in 2023 was $70.84B, surged 103.2% from 2022. This figure represents the highest annual value in the available history.
Pfizer Total Debt 2022: $34.86B
Pfizer total debt in 2022 was $34.86B, declined 5.8% below 2021.
Pfizer Total Debt 2021: $37.00B
Pfizer total debt in 2021 was $37.00B.
See more financial history for Pfizer (PFE).
Sector peers — Total Debt
Companies in the same sector as Pfizer, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Pfizer's total debt?
- Latest reported total debt for Pfizer (PFE) is $67.42B (period ending December 31, 2025).
How has Pfizer total debt changed year-over-year?
- Pfizer (PFE) total debt changed +0.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Pfizer total debt?
- Pfizer (PFE) total debt compound annual growth rate is +12.0% over the most recent 5 years available.
When did Pfizer total debt hit its highest annual value?
- Pfizer total debt reached its highest annual value of $70.84B in 2023.
What was Pfizer total debt in 2024?
- Pfizer (PFE) total debt in 2024 was $66.99B.
What was Pfizer total debt in 2025?
- Pfizer (PFE) total debt in 2025 was $67.42B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PFE Overview
Company profile, financial tools, and key metrics
PFE Revenue Counter
Earns $1,984 every second. See per minute, hour, and day.
PFE Earnings Counter
Earns $246.39 per second net profit. See per minute, hour, and day.
PFE Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
PFE What If Invested
What if you had invested $1,000? See historical returns from any date.
PFE How It Makes Money
Discover visual breakdown of $62.58B in revenue — where it comes from and where it goes.
PFE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PFE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PFE Daily Price Character
Steady · 46.3% historical win rate (green days). Streaks & record days.
PFE Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
PFE Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
PFE Dividend Profile
Yield: 6.55%. Safety: 3/8. See full history.
PFE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
PFE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.